p.E1051D | TCGA-AA-3811 | COAD | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.3056 |
p.D1065N | TCGA-AA-3864 | COAD | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.R1046H | TCGA-AJ-A3BH | UCEC | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.R1046H | TCGA-AX-A0J1 | UCEC | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.E1068K | TCGA-AO-A03M | BRCA | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.0833 |
p.R1046C | TCGA-AP-A1DV | UCEC | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.D1063A | TCGA-EK-A2PL | CESC | TCGA | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.2222 |
p.S1048T | DO50224 | LGG | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.3333 |
p.N1053K | DO228948 | LICA | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.6918 |
p.S1048I | DO27247 | LUSC | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.3333 |
p.P1044L | DO220900 | MELA | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1111 |
p.P1044S | DO220900 | MELA | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1111 |
p.V1046I | DO229446 | SKCA | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.G1069E | DO37839 | SKCM | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.5 |
p.K1061T | DO43907 | UCEC | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.2778 |
p.V1065A | DO41235 | UCEC | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.S1048R | DO42673 | UCEC | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.3333 |
p.S1048R | Ramos-2G6-4C10 | haematopoietic_and_lymphoid_tissue | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.3333 |
p.I1064S | DO41331 | UCEC | ICGC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1944 |
p.T1056I | SIDM00427 | Ewing's Sarcoma | GDSC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7078 |
p.T1056I | SIDM00258 | Neuroblastoma | GDSC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7078 |
p.T1056I | SIDM00659 | Glioblastoma | GDSC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7078 |
p.T1056I | SIDM00594 | Acute Myeloid Leukemia | GDSC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7078 |
p.T1056I | SIDM00882 | Breast Carcinoma | GDSC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7078 |
p.T1055M | ACH-000151 | Leukemia | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7423 |
p.T1055M | JM1 | haematopoietic_and_lymphoid_tissue | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7423 |
p.S1053R | ACH-000362 | Leukemia | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.S1053R | ACH-000500 | Head and Neck Cancer | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.S1053R | ACH-001574 | Leukemia | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.S1053R | ACH-001642 | Lymphoma | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.S1053R | SCC-3 | haematopoietic_and_lymphoid_tissue | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.S1053R | MOLM-13 | haematopoietic_and_lymphoid_tissue | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7427 |
p.I1045N | ACH-000611 | Lymphoma | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1389 |
p.D1052N | ACH-001552 | Skin Cancer | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.6932 |
p.D1052N | MCC26 | skin | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.6932 |
p.S1046P | ACH-002015 | Eye Cancer | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.1667 |
p.Y1068H | ACH-002099 | Bone Cancer | CCLE | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.0833 |
p.Y1068H | CS1 | bone | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.0833 |
p.S1068N | MFE-319 | endometrium | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.0833 |
p.S1068G | YAPC | pancreas | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.0833 |
p.M1059I | PANC-04-03 | pancreas | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.7618 |
p.V1056L | NCI-H1915 | lung | COSMIC | FEDLTPGK | DEG_SCF_SKP2-CKS1_1 | 0.6765 |